Hetero Drugs Limited, a pharmaceutical company, develops, manufactures, and markets active pharmaceutical ingredients (APIs), intermediate chemicals, and generic finished dosages for the biopharmaceutical industry. It offers APIs, including cytotoxics to the pharmaceutical companies that manufacture formulations and other products; generic formulations; CPS; biologics; anti-retroviral drugs; and biosimilar drugs, including monoclonal antibodies, as well as Adalimumab, an anti-inflammatory biologic medication specific for human tumor necrosis factor.
Hetero Drugs Limited, a pharmaceutical company, develops, manufactures, and markets active pharmaceutical ingredients (APIs), intermediate chemicals, and generic finished dosages for the biopharmaceutical industry. It offers APIs, including cytotoxics to the pharmaceutical companies that manufacture formulations and other products; generic formulations; CPS; biologics; anti-retroviral drugs; and biosimilar drugs, including monoclonal antibodies, as well as Adalimumab, an anti-inflammatory biologic medication specific for human tumor necrosis factor.
Position: Account Executive
Company Name: Hetero Drugs Limited